Comparison

AMGEN INC (AMGN) vs TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

The same filed metrics for both companies, side by side.

What each names as a risk in its own annual report, how each is priced against its own history, and the tracked managers whose latest 13F reports a position in both.

Financials

AMGN

AMGEN INC

Drug Manufacturers—General

Revenue, FY25: $36.75B
Net income: $7.71B
Operating cash flow: $9.96B
Free cash flow: $8.1B
Net margin: 20.98%
Operating margin: 24.71%
Gross margin: 67.25%

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD

Drug Manufacturers—Specialty & Generic

Revenue, FY25: $17.26B
Net income: $1.41B
Operating cash flow: $1.65B
Free cash flow: -
Net margin: 8.17%
Operating margin: 12.50%
Gross margin: 51.79%

Head-to-head

Filed growth, quality and valuation, read against each company’s own history rather than against the other side.

Metric	AMGN	TEVA
Revenue growth, latest filed year	+9.95%	+4.32%
Piotroski F-score	7 of 9	7 of 8
P/E against its own history	about normal	-

What each says it is exposed to

From Item 1A of each company’s most recent 10-K.

AMGN

FDA approval
Reimbursement
Cybersecurity
Litigation
China
Tax

And 20 more.

TEVA

No 10-K read yet.

Tracked managers holding both

No manager tracked here reports a position in both, as of each company’s latest filed 13F.

Updated Sep 16, 2026 · the newer of the two companies' filings